Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Nuclear Medicine Clarification Act of 2025
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection. HR 2541, Nuclear Medicine Clarification Act. A bill related to medical event reporting.
Nuclear Medicine Clarification Act of 2025
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2026 · second_quarter · Q2
Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection. HR 2541, Nuclear Medicine Clarification Act. A bill related to medical event reporting.
Theranostics report language in the Labor, Health and Human Services, Education, and Related Agencies (L-HHS) funding legislation. This language would help ensure that existing federal research funds allocated through the NIHs National Cancer Institute (NCI) can be leveraged, as appropriate, to further advance the field of theranostics and benefit Americans facing cancer.
Source: Senate LDA
Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection. HR 2541, Nuclear Medicine Clarification Act. A bill related to medical event reporting.
Find It Early Act
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection. HR 2541, Nuclear Medicine Clarification Act. A bill related to medical event reporting.
Find It Early Act
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection. HR 2541, Nuclear Medicine Clarification Act. A bill related to medical event reporting.
Nuclear Medicine Clarification Act of 2025
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection. HR 2541, Nuclear Medicine Clarification Act. A bill related to medical event reporting.
Nuclear Medicine Clarification Act of 2025
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection. HR 2541, Nuclear Medicine Clarification Act. A bill related to medical event reporting.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Medicare Physician Fee Schedule reform legislation, Medicare Patient Access and Practice Stabilization Act (H.R. 879)
Medicare Patient Access and Practice Stabilization Act of 2025
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Medicare Physician Fee Schedule reform legislation, Medicare Patient Access and Practice Stabilization Act (H.R. 879)
Medicare Patient Access and Practice Stabilization Act of 2025
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Medicare Physician Fee Schedule reform legislation, Medicare Patient Access and Practice Stabilization Act (H.R. 879)
Medicare Patient Access and Practice Stabilization Act of 2025
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Medicare Physician Fee Schedule reform legislation, Medicare Patient Access and Practice Stabilization Act (H.R. 879)
Find It Early Act
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection. HR 2541, Nuclear Medicine Clarification Act. A bill related to medical event reporting.
Find It Early Act
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection.
Find It Early Act
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection. HR 2541, Nuclear Medicine Clarification Act. A bill related to medical event reporting.
Find It Early Act
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
HR 1199 Facilitating Innovative Nuclear Diagnostics Act of 2023 S 1544 Facilitating Innovative Nuclear Diagnostics Act of 2023
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
The Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023, HR 1199, S 1544 The Nuclear Medicine Clarification Act, HR 6815
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
HR 1199 Facilitating Innovative Nuclear Diagnostics Act of 2023 S 1544 Facilitating Innovative Nuclear Diagnostics Act of 2023
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
The Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023, HR 1199, S 1544 The Nuclear Medicine Clarification Act, HR 6815
Nuclear Medicine Clarification Act of 2023
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
The Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023, HR 1199, S 1544 The Nuclear Medicine Clarification Act, HR 6815
Nuclear Medicine Clarification Act of 2023
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
The Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023, HR 1199, S 1544 The Nuclear Medicine Clarification Act, HR 6815
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
The Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023, HR 1199, S 1544 The Nuclear Medicine Clarification Act, HR 6815
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
HR 1199 Facilitating Innovative Nuclear Diagnostics Act of 2023 S 1544 Facilitating Innovative Nuclear Diagnostics Act of 2023
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
HR 1199 Facilitating Innovative Nuclear Diagnostics Act of 2023 S 1544 Facilitating Innovative Nuclear Diagnostics Act of 2023
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
The Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023, HR 1199, S 1544 The Nuclear Medicine Clarification Act, HR 6815
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
HR 1199, FIND Act, radiopharmaceutical reimbursement
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
HR 1199, FIND Act, radiopharmaceutical reimbursement
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
HR 1199, FIND Act, radiopharmaceutical reimbursement
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
HR 1199, FIND Act, radiopharmaceutical reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2026 · first_quarter · Q1
Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection. HR 2541, Nuclear Medicine Clarification Act. A bill related to medical event reporting.
Theranostics report language in the Labor, Health and Human Services, Education, and Related Agencies (L-HHS) funding legislation. This language would help ensure that existing federal research funds allocated through the NIHs National Cancer Institute (NCI) can be leveraged, as appropriate, to further advance the field of theranostics and benefit Americans facing cancer.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2025 · fourth_quarter · Q4
Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection. HR 2541, Nuclear Medicine Clarification Act. A bill related to medical event reporting.
Theranostics report language in the FY26 Labor, Health and Human Services, Education, and Related Agencies (L-HHS) funding legislation. This language would help ensure that existing federal research funds allocated through the NIHs National Cancer Institute (NCI) can be leveraged, as appropriate, to further advance the field of theranostics and benefit Americans facing cancer.
Medicare Physician Fee Schedule reform legislation, Medicare Patient Access and Practice Stabilization Act (H.R. 879)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2025 · third_quarter · Q3
Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection. HR 2541, Nuclear Medicine Clarification Act. A bill related to medical event reporting.
Theranostics report language in the FY26 Labor, Health and Human Services, Education, and Related Agencies (L-HHS) funding legislation. This language would help ensure that existing federal research funds allocated through the NIHs National Cancer Institute (NCI) can be leveraged, as appropriate, to further advance the field of theranostics and benefit Americans facing cancer.
Medicare Physician Fee Schedule reform legislation, Medicare Patient Access and Practice Stabilization Act (H.R. 879)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2025 · second_quarter · Q2
Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection.
Theranostics report language in the FY26 Labor, Health and Human Services, Education, and Related Agencies (L-HHS) funding legislation. This language would help ensure that existing federal research funds allocated through the NIHs National Cancer Institute (NCI) can be leveraged, as appropriate, to further advance the field of theranostics and benefit Americans facing cancer.
Medicare Physician Fee Schedule reform legislation, Medicare Patient Access and Practice Stabilization Act (H.R. 879)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2025 · first_quarter · Q1
Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection.
Theranostics report language in the FY26 Labor, Health and Human Services, Education, and Related Agencies (L-HHS) funding legislation. This language would help ensure that existing federal research funds allocated through the NIHs National Cancer Institute (NCI) can be leveraged, as appropriate, to further advance the field of theranostics and benefit Americans facing cancer.
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2024 · fourth_quarter · Q4
Department of Defense Appropriations bill, Congressionally Directed Medical Research Programs
HR 1199 Facilitating Innovative Nuclear Diagnostics Act of 2023 S 1544 Facilitating Innovative Nuclear Diagnostics Act of 2023
The Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023, HR 1199, S 1544 The Nuclear Medicine Clarification Act, HR 6815
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2024 · third_quarter · 3A
The Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023, HR 1199, S 1544 The Nuclear Medicine Clarification Act, HR 6815
Department of Defense Appropriations bill, Congressionally Directed Medical Research Programs
HR 1199 Facilitating Innovative Nuclear Diagnostics Act of 2023 S 1544 Facilitating Innovative Nuclear Diagnostics Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2023 · fourth_quarter · Q4
HR 1199, FIND Act, radiopharmaceutical reimbursement
Including bill language referencing nuclear medicine in federal grants.
NRC Rulemaking
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2023 · third_quarter · Q3
Including bill language referencing nuclear medicine in federal grants.
NRC Rulemaking
HR 1199, FIND Act, radiopharmaceutical reimbursement
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2023 · second_quarter · Q2
Medicare Physician Fee Schedule, OPPS
Including bill language referencing nuclear medicine in federal grants.
NRC Rulemaking
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2023 · first_quarter · Q1
NRC Rulemaking
Medicare Physician Fee Schedule, OPPS
HR 1199, FIND Act, radiopharmaceutical reimbursement
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2022 · fourth_quarter · Q4
Compounding, preparation, packaging and dispensing of radiopharmaceuticals
Medicare coverage and reimbursement related to diagnostic radiopharmaceuticals in the outpatient hospital setting
Stable supply of isotopes used for medical purposes
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2022 · third_quarter · Q3
Medicare coverage and reimbursement
Stable supply of isotopes used for medical purposes
Compounding, preparation, packaging and dispensing of radiopharmaceuticals
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2022 · second_quarter · Q2
Stable supply of isotopes used for medical purposes
Medicare coverage and reimbursement
Compounding, preparation, packaging and dispensing of radiopharmaceuticals
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2022 · first_quarter · Q1
Compounding, preparation, packaging and dispensing of radiopharmaceuticals
Medicare coverage and reimbursement related to diagnostic radiopharmaceuticals in the outpatient hospital setting
Stable supply of isotopes used for medical purposes
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2021 · fourth_quarter · Q4
Stable supply of isotopes used for medical purposes
Compounding, preparation, packaging and dispensing of radiopharmaceuticals
Medicare coverage and reimbursement related to diagnostic radiopharmaceuticals in the outpatient hospital setting
Medicare Physician Fee Schedule reform legislation, Medicare Patient Access and Practice Stabilization Act (H.R. 879)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Nuclear Regulatory Commission (NRC), SENATE
Medicare Physician Fee Schedule, OPPS
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
Medicare Physician Fee Schedule, OPPS
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
HR 1199, FIND Act, radiopharmaceutical reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), Office of Science & Technology Policy (OSTP), SENATE
Including bill language referencing nuclear medicine in federal grants.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), Office of Science & Technology Policy (OSTP), SENATE
Medicare coverage and reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), Office of Science & Technology Policy (OSTP), SENATE
Medicare coverage and reimbursement related to diagnostic radiopharmaceuticals in the outpatient hospital setting
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), Office of Science & Technology Policy (OSTP), SENATE
Medicare coverage and reimbursement related to diagnostic radiopharmaceuticals in the outpatient hospital setting
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), Office of Science & Technology Policy (OSTP), SENATE
Medicare coverage and reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), Office of Science & Technology Policy (OSTP), SENATE
Medicare coverage and reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), Office of Science & Technology Policy (OSTP), SENATE